© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 5MCG/0.5ML 1ST | Medium Descr | IMM ADMN SARSCOV2 5 MCG/0.5 ML 1ST DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; first dose | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | CR | Catastrophe/disaster related | GA | Waiver of liability statement issued as required by payer policy, individual case |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2022-10-19 | Note | AMA guideline changed. 0044A received FDA approval |
| 2022-10-10 | Note | AMA guideline changed to include 0044A effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-10-10 | Note | Changes made to include 12 years and older. |
| 2022-08-31 | Note | Changes made to vaccine patient age (18+). |
| 2022-07-13 | Added | Received FDA approval |
| 2022-07-13 | Note | AMA Guideline changed. 0042A received FDA approval. |
| 2022-07-13 | Note | AMA guideline changed. FDA approval received for 91304. Approval published to website 2022-07-26. FDA approval effective retroactively to 2022-07-13. |
| 2022-01-01 | Note | First appearance in Codebook |
| 2022-01-01 | Changed | Code description changed. |
| 2021-05-04 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |
| 2021-05-04 | Note | AMA guideline changed to include 0042A, 91304 effective upon receiving Emergency Use Authorization or approval from the FDA. |